Anthony Unger, MD
Adult Reconstructive Orthopaedic Surgery · Washington, DCNPI 1316052541
Payments from drug & device makers
Across 91 payments — averaging $17,447 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Zimmer Biomet$1.5M
- Signature Orthopaedics USA Corp$91K
- Smith+Nephew$22K
- Stryker$1K
- Hikma Pharmaceuticals USA$344
- Davol Inc.$203
- plus $161 from 5 others
What the payments were for
- Royalty or licence$1,551,53198%
- Consulting fees$26,1562%
- Speaking & faculty fees$3,5000%
- Travel & lodging$3,8170%
- Food & beverage$2,6720%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Zimmer Biomet | 30 | $1,472,763 |
| Signature Orthopaedics USA Corp | 5 | $91,079 |
| Smith+Nephew | 28 | $21,817 |
| Stryker | 17 | $1,310 |
| Hikma Pharmaceuticals USA | 1 | $344 |
| Davol Inc. | 3 | $203 |
| Bioventus LLC | 2 | $57 |
| Johnson & Johnson | 2 | $35 |
| Pacira Therapeutics, Inc. | 1 | $28 |
| Mallinckrodt Enterprises LLC | 1 | $21 |
| Heraeus Medical, LLC. | 1 | $20 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Persona$1,009,255
- Persona The Personalized Knee OsseoTi$451,196
- Journey II$17,676
- LEGION TKS$13,938
- Knees Product Portfolio$7,750
- ROSA$4,026
- Journey II BCS$3,619
- CORI$3,614
- Journey II CR$3,601
- BIRMINGHAM HIP$3,500
- Anthology$3,500
- Legion$1,375
- NAV - ORTHOMAP 3D NAVIGATION SOFTWARE/INSTRUMENTATION$392
- COMBOGESIC IV$344
- ORTHOMAP$281
- MAKO$165
- POLARSTEM$119
- VISIONAIRE Cutting Guides$101
How this compares
Too few adult reconstructive orthopaedic surgery providers in District of Columbiato place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 31 | $791 |
| Amoxicillin | 156 | $398 |
| Tramadol Hcl | 43 | $272 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 20 | $260 |
| Methylprednisolone | 21 | $246 |
| Cefadroxil | 18 | $158 |
| Diclofenac Sodium | 17 | $145 |
| Clindamycin Hcl | 22 | $81 |
| Oxycodone Hcl | 12 | $63 |
| Meloxicam | 11 | $55 |
Paid to pharmacies, not to this prescriber.
Other adult reconstructive orthopaedic surgery in Washington
- Surajudeen BolarinwaWashington$24K
- Katharine HarperWashington$18K
- Matthew HarbWashington$3K
- Afamefuna NduagubaWashington$2K
- Mark ZawadskyWashington$170
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.